```html

Trench Fever – A Comprehensive Medical Guide

Overview

Trench fever is an acute, relapsing bacterial infection caused by Bergeria quintana (formerly Rickettsia quintana). It is transmitted primarily by the human body louse (Pediobius humanus) and, less commonly, by contaminated clothing or fleas.

The disease earned its name during World War I, when thousands of soldiers in the cramped, unhygienic trenches developed a fever‑ish illness with severe leg pain. Today, trench fever is rare in high‑income countries but remains a public health concern in crowded, low‑resource settings such as homeless shelters, refugee camps, and among people living in sub‑standard housing.

Who it affects

• People with prolonged exposure to body lice, especially in crowded or unhygienic environments.
• Homeless individuals, migrants, and those living in institutional settings.
• Military personnel deployed in austere field conditions (historically).

Prevalence

• In the United States, documented cases are < 10 per year, mostly among homeless populations.
• In Europe, periodic outbreaks have been reported in France, Italy, and Spain, with incidence rates ranging from 0.5–2 cases per 100,000 people in high‑risk groups.
• World Health Organization (WHO) does not list trench fever as a notifiable disease, so global numbers are likely under‑reported.

Despite its rarity, the disease can cause significant morbidity if not recognized and treated promptly. [CDC, 2023; WHO, 2022]

Symptoms

Symptoms usually appear 5–15 days after the bite of an infected louse. The classic picture is a triad of fever, severe leg pain, and a rash, but presentation can be variable.

Typical (most common) manifestations

• Fever – sudden onset of high temperature (38–40 °C / 100–104 °F), often with chills.
• Headache – usually dull, may be throbbing.
• Myalgia – especially in the calves and thighs; pain can be intense enough to mimic deep‑vein thrombosis.
• Rash – faint, pink maculopapular spots on the trunk and limbs; may be absent in up to 30 % of cases.
• Joint pain (arthralgia) – typically symmetric, affecting ankles and knees.
• Photophobia – sensitivity to light, less common.

Relapsing pattern

After 4–7 days of improvement, fever and pain may recur every 4–10 days for up to 3–4 weeks. This pattern is a key clue to trench fever.

Atypical or severe features

• Splenomegaly (enlarged spleen)
• Hepatomegaly (enlarged liver)
• Neurologic signs – rarely meningitis or encephalitis
• Cardiac involvement – myocarditis (extremely rare)

Most patients recover without sequelae, but untreated infection can lead to prolonged fatigue and musculoskeletal pain lasting months.

Causes and Risk Factors

Trench fever is caused by the bacterium Bergeria quintana. The organism multiplies in the gut of the human body louse and is excreted in louse feces. Transmission occurs when contaminated feces are scratched into abraded skin or when a louse is crushed on the skin.

Primary risk factors

• Body‑louse infestation – the single most important factor.
• Overcrowded living conditions – shelters, prisons, refugee camps.
• Poor personal hygiene – infrequent changing of clothing or washing.
• Homelessness – limited access to laundry facilities.
• Travel to endemic regions – especially in Eastern Europe, the Middle East, and parts of Africa.

Additional considerations

• Immunocompromised individuals may experience a longer disease course.
• Co‑infection with other louse‑borne diseases (e.g., epidemic typhus) can occur.

Diagnosis

Because trench fever mimics many other febrile illnesses, a combination of clinical suspicion and laboratory testing is required.

Clinical assessment

• History of exposure to lice or living in high‑risk settings.
• Characteristic relapsing fever with severe leg pain.

Laboratory tests

• Serology – detection of IgM/IgG antibodies against B. quintana (ELISA or indirect immunofluorescence). Sensitivity ~85 % after 2 weeks of illness.
• Polymerase chain reaction (PCR) – most accurate; can be performed on blood, skin biopsy, or louse specimens. Provides rapid confirmation.
• Blood culture – rarely positive; B. quintana is fastidious.
• Complete blood count (CBC) – often shows mild anemia and a modest leukocytosis or leukopenia.
• Liver function tests – may be mildly elevated.

Differential diagnosis

Conditions that must be ruled out include:

• Epidemic typhus (Rickettsia prowazekii)
• Murine typhus (Rickettsia typhi)
• Q fever (Coxiella burnetii)
• Leptospirosis
• Malaria (in travelers)
• Viral exanthems (e.g., dengue)
• Deep‑vein thrombosis or cellulitis (due to leg pain)

Treatment Options

Trench fever responds well to antibiotics. Early treatment shortens the disease course and reduces relapses.

First‑line antibiotics

• Doxycycline 100 mg orally twice daily for 7–10 days (preferred for adults).
• Azithromycin 500 mg orally once daily for 5 days – useful for patients who cannot tolerate doxycycline (e.g., pregnancy).

Alternative regimens

• Chloramphenicol 500 mg orally four times daily for 7–10 days (reserved for severe cases or doxycycline‑resistant strains).
• Minocycline 100 mg orally twice daily for 7 days (alternative for doxycycline intolerance).

Supportive care

• Antipyretics (acetaminophen or ibuprofen) for fever and pain.
• Hydration – ensure adequate fluid intake.
• Rest and elevation of the legs to alleviate calf pain.

Louse eradication

Successful treatment of the patient must be accompanied by measures to eliminate the vector:

1. Launder clothing and bedding at ≥ 60 °C (140 °F) or discard if not washable.
2. Apply topical insecticide (permethrin 1 %) to personal items.
3. Frequent bathing and changing of garments.

Living with Trench Fever

Even after antibiotics, some individuals report lingering fatigue or muscle aches for weeks. The following strategies help manage residual symptoms:

• Gradual return to activity – start with light walking and increase duration slowly.
• Physical therapy – particularly for calf muscle stiffness.
• Balanced nutrition – protein‑rich foods support tissue repair.
• Sleep hygiene – aim for 7–9 hours of restorative sleep.
• Psychological support – chronic pain can cause anxiety; counseling or support groups are beneficial.

For individuals experiencing homelessness or living in crowded housing, connecting with social services that provide clean clothing, laundry facilities, and stable shelter is essential for preventing re‑infestation.

Prevention

Because the disease is louse‑borne, prevention centers on hygiene and environmental control.

Individual measures

• Daily bathing and changing into clean clothes.
• Inspect clothing and skin for lice; wash infested items in hot water (≥ 60 °C) and dry on high heat.
• Avoid sharing clothing, towels, or bedding.
• Use a louse‑killing shampoo or permethrin‑based spray if infestation is suspected.

Community‑level interventions

• Provide accessible laundry facilities in shelters and detention centers.
• Implement regular screening for body lice in high‑risk populations.
• Education campaigns about personal hygiene and signs of louse infestation.
• Rapid response teams to treat outbreaks in refugee camps.

Complications

While most cases resolve without lasting damage, untreated or delayed treatment can lead to:

• Chronic fatigue syndrome – prolonged malaise lasting months.
• Persistent musculoskeletal pain – especially in calves and knees.
• Endocarditis – rare, but documented in immunocompromised patients.
• Neurologic sequelae – meningitis or encephalitis (very rare).
• Secondary bacterial infections – from scratching louse bites.

Early antibiotic therapy dramatically reduces the risk of these complications. [Cleveland Clinic, 2023; NIH, 2022]

When to Seek Emergency Care

References

1. Centers for Disease Control and Prevention. “Trench Fever (Louse‑borne Spotted Fever).” 2023. cdc.gov.
2. World Health Organization. “Vector‑borne diseases: Louse‑borne infections.” 2022.
3. Mayo Clinic. “Trench fever.” 2023. mayoclinic.org.
4. Cleveland Clinic. “Rickettsial Diseases – Diagnosis & Treatment.” 2023.
5. National Institutes of Health, National Center for Emerging & Zoonotic Infectious Diseases. “Bergeria quintana.” 2022.
6. European Centre for Disease Prevention and Control. “Surveillance of louse‑borne diseases in Europe.” 2021.

```